Inorganic Chemistry
Article
cyclohexane. 1H NMR (CD2Cl2): 7.50−8.10 (br, 4H, P-
(C6H5)3), 7.03−7.49 (m, 12H, P(C6H5)3 and CimidazoleH),
6.45−6.85 (br, 1H, P(C6H5)3), 1.33−1.45 (m, 18H, N−
C(CH3)3 and P(C(CH3)3)2), 1.05 (d, J = 14.9 hz, 9H,
P(C(CH3)3)2). 31P{1H} NMR (CD2Cl2): 110.8 (d, J = 41.5 Hz,
P(C(CH3)3)2), 72.6 (d, J = 41.4 Hz, P(C6H5)3). 13C{1H} NMR
(CD2Cl2): 171.4 (m, NCN), 135.2 (m, P(C6H5)3), 130.1 (m,
P(C6H5)3), 128.0 (m, P(C6H5)3), 122.7 (d, J = 7.0 Hz,
appropriate riding models, goodness of fit 1.03 for observed
reflections, final residual values R1(F) = 0.038, wR(F2) = 0.073
for observed reflections, residual electron density −0.99 to 1.22
e·Å−3.
Synthesis of 4aBr. 3a (2.15 g, 3.25 mmol) was dissolved in 3-
bromopyridine (2−3 mL) without stirring. Within 30 min
orange crystals formed. The 3-bromopyridine was decanted and
Et2O (2 × 15 mL) was added, stirred, and filtered to isolate
4aBr (1.89 g, 2.64 mmol, 82%) as orange crystals.The crystals
initially formed were of sufficient quality for single crystal X-ray
diffraction. 1H NMR (C5D5N): 11.2, 8.83 (m, free 3-
bromopyridine), 8.74 (residual pyridine), 8.60 (m, free 3-
bromopyridine), 8.09, 7.91, 7.85−7.81 (m, free 3-bromopyr-
idine), 7.73, 7.59 (residual pyridine), 7.22 (residual pyridine),
7.18−7.12 (m, free 3-bromopyridine), 6.98, 6.60, 4.67, 4.25,
3.78, 3.61, 1.43 (d, 12.2 Hz, P(C(CH3)3)), 1.37 (d, 11.9 Hz,
P(C(CH3)3)), 1.06 (d, 13.5 Hz, P(C(CH3)3)), 1.05 (d, 13.7
Hz, P(C(CH3)3)). 31P{1H} NMR (C5D5N): 115.8, 109.3,
89.0, 64.6. 13C{1H} NMR (C5D5N): 184.1, 180.6, 179.4, 152.5,
149.7, 140.1, 130.0, 129.4, 129.2, 128.5, 127.1, 126.7, 122.5,
119.1, 42.8, 42.5, 42.4, 41.6, 39.3, 38.3, 37.2, 30.85, 30.81,
30.77, 30.51, 30.46. Elemental analysis C22H31Br2Cl2N4PRu
calculated: C 36.99%, H 4.37%, N 7.84% Found: C 37.04%, H
4.32%, N 8.04%.
CimidazoleH), 121.9 (d, J = 1.5 Hz, CimidazoleH), 59.7 (s, N-
C(CH3)3), 43.8 (d, J = 10.5 Hz, P-C(CH3)3), 37.3 (s, N−
C(CH3)3), 30.1 (s, N−C(CH3)3), 29.1 8 (d, J = 5.0 Hz, P−
C(CH3)3), 27.0 (d, J = 3.6 Hz, P−C(CH3)3). Elemental
analysis C33H44Cl2N2P2Ru calculated: C 56.41%, H 6.31%, N
3.99% Found: C 56.65%, H 6.61%, N 4.17%.
Violet crystal (plate), dimensions 0.090 × 0.080 × 0.060
mm3, crystal system monoclinic, space group P21, Z = 4, a =
10.5570(10) Å, b = 17.4081(17) Å, c = 19.9446(18) Å, α = 90°,
β = 91.141(2)°, γ = 90°, V = 3664.6(6) Å3, ρ = 1.427 g/cm3, T
= 200(2) K, θmax = 24.807°, radiation Mo Kα, λ = 0.71073 Å,
0.5° ω-scans with CCD area detector, covering the asymmetric
unit in reciprocal space with a mean redundancy of 3.33 and a
completeness of 99.5% to a resolution of 0.85 Å, 21833
reflections measured, 12376 unique (R(int) = 0.0712), 8056
observed (I > 2σ(I)), μ = 0.83 mm−1, Tmin = 0.75, Tmax = 0.96,
775 parameters refined, hydrogen atoms were treated using
appropriate riding models, Flack absolute structure parameter
0.13(3), goodness of fit 1.03 for observed reflections, final
residual values R1(F) = 0.076, wR(F2) = 0.106 for observed
reflections, residual electron density −1.13 to 1.14 e·Å−3.
Synthesis of 4aH. 3a (280 mg, 0.42 mmol) was dissolved in
pyridine (3 mL) without stirring. Within 30 min orange crystals
formed. The pyridine was decanted and hexanes (15 mL) was
added, stirred, and filtered to isolate 4aH (203 mg, 0.365 mmol,
87%) as orange crystals. X-ray quality single crystals were
Orange crystal (polyhedron), dimensions 0.17 × 0.12 × 0.11
mm3, crystal system monoclinic, space group Cc, Z = 4, a =
18.609(3) Å, b = 19.892(3) Å, c = 8.7676(15) Å, α = 90°, β =
113.047(3)°, γ = 90°, V = 2986.5(9) Å3, ρ = 1.589 g/cm3, T =
200(2) K, θmax = 25.95°, radiation Mo Kα, λ = 0.71073 Å, 0.5°
ω-scans with CCD area detector, covering the asymmetric unit
in reciprocal space with a mean redundancy of 2.90 and a
completeness of 97.7% to a resolution of 0.82 Å, 8498
reflections measured, 2864 unique (R(int) = 0.0640), 2499
observed (I > 2σ(I)), μ = 3.45 mm−1, Tmin = 0.59, Tmax = 0.70,
310 parameters refined, hydrogen atoms were treated using
appropriate riding models, Flack absolute structure parameter
0.46(3), goodness of fit 1.06 for observed reflections, final
residual values R1(F) = 0.045, wR(F2) = 0.086 for observed
reflections, residual electron density −0.81 to 0.72 e·Å−3.
Synthesis of 4bBr. 3b (1.26 g, 1.83 mmol) was dissolved in
3-bromopyridine (3 mL) without stirring. Within 30 min
orange crystals formed. The 3-bromopyridine was decanted and
Et2O (3 × 20 mL) was added, stirred, and filtered to isolate
1
isolated from the layering of CH2Cl2 and cyclohexane. H
NMR (C5D5N): 8.73 (m, C5D5Nresidual and C5H5N), 8.23 (m,
CHimidazole), 7.99 (s, CHimidazole), 7.98 (s, CHimidazole), 7.90 (s,
CHimidazole), 7.59 (m, C5D5Nresidual and C5H5N), 7.22 (m,
C5D5Nresidual and C5H5N), 4.68 (s, CH3), 4.26 (s, CH3), 1.03
(m, P(C(CH3)3)2). 31P{1H} NMR (C5D5N): 113.9, 107.5.
13C{1H} NMR (C5D5N): 179.0 (d, J = 13.9 Hz, NCN), 177.7
(d, J = 13.3 Hz, NCN), 150.1, 150.0, 135.8, 135.6, 128.1 (s,
CHimidazole), 128.0 (s, CHimidazole), 125.7 (d, J = 7.2 Hz,
CHimidazole), 125.2 (d, J = 7.2 Hz, CHimidazole), 123.9, 123.6, 41.3
(d, J = 2.2 Hz, P(C(CH3)3)2), 40.0 (d, J = 2.1 Hz,
P(C(CH3)3)2), 36.9 (s, CH3), 35.7 (s, CH3), 29.3 (d, J = 5.2
Hz, P(C(CH3)3)2), 29.0 (d, J = 5.2 Hz, P(C(CH3)3)2).
Elemental analysis C22H33Cl2N4PRu·2CH2Cl2 calculated: C
39.69%, H 5.31%, N 7.71% Found: C 40.36%, H 5.21%, N
7.99%. As in the elemental analysis of 3a repeated attempts
were made to obtain better EA data but results were
inconsistent, presumably due to residual solvent.
Orange crystal (polyhedron), dimensions 0.26 × 0.16 × 0.16
mm3, crystal system monoclinic, space group P21/c, Z = 4, a =
8.6967(7) Å, b = 15.7760(12) Å, c = 22.6971(17) Å, α = 90°, β
= 93.707(1)°, γ = 90°, V = 3107.5(4) Å3, ρ = 1.552 g/cm3, T =
199(2) K, θmax = 28.71°, radiation Mo Kα, λ = 0.71073 Å, 0.5°
ω-scans with CCD area detector, covering the asymmetric unit
in reciprocal space with a mean redundancy of 4.68 and a
completeness of 99.1% to a resolution of 0.74 Å, 38123
reflections measured, 7973 unique (R(int) = 0.0573), 6072
observed (I > 2σ(I)), μ = 1.09 mm−1, Tmin = 0.76, Tmax = 0.84,
332 parameters refined, hydrogen atoms were treated using
1
4bBr (1.28 g, 1.72 mmol, 94%) as orange crystals. H NMR
(CD2Cl2): 10.45, 10.37, 10.30, 9.24, 9.18, 8.97, 8.91, 8.67, 8.51,
8.20, 8.10, 7.83, 7.68, 7.27, 7.21, 7.09, 6.92, 6.87, 5.96 (m,
NCH(CH3)2), 4.23 (m, NCH(CH3)2), 1.56−1.33 (m, NCH-
(CH3)2) and P(C(CH3)3)2), 1.03 (m, NCH(CH3)2) and
P(C(CH3)3)2). 31P{1H} NMR (CD2Cl2): 122.1, 120.0, 119.9.
13C{1H} NMR (CD2Cl2): 184.3 (m, NCN), 158.4, 157.9,
157.4, 156.4, 154.5, 153.7, 151.0, 148.0, 138.5, 138.2, 137.9,
124.9, 124.7, 124.6, 124.1, 120.8, 119.2, 118.8, 118.1, 50.6, 49.4,
41.0, 40.3, 30.0 (d, 5.7 Hz), 29.7, 23.6, 23.5. Elemental analysis
C24H35Br2Cl2N4PRu calculated: C 38.83%, H 4.75%, N 7.55%
Found: C 38.79%, H 4.71%, N 7.64%.
Synthesis of 4cBr. 3c (1.44 g, 2.05 mmol) was dissolved in 3-
bromopyridine (3 mL) without stirring. Within 30 min orange
crystals formed. The 3-bromopyridine was decanted and Et2O
(10 mL) was added, stirred, and filtered to isolate 4cBr (1.43 g,
1.89 mmol, 92%) as orange crystals. The crystals initially
formed were of sufficient quality for single crystal X-ray
1
diffraction. H NMR (NC5D5): 8.84 (d, J = 2.5 Hz, free 3-
bromopyridine), 8.74 (s, residual pyridine), 8.60 (dd, J = 4.7
L
Inorg. Chem. XXXX, XXX, XXX−XXX